Eagle Pharmaceuticals Inc (EGRX)
4.41
+0.01
(+0.23%)
USD |
NASDAQ |
May 03, 16:00
4.415
0.00 (0.00%)
After-Hours: 20:00
Eagle Pharmaceuticals Max Drawdown (5Y): 93.70% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 93.70% |
March 31, 2024 | 93.38% |
February 29, 2024 | 93.38% |
January 31, 2024 | 93.38% |
December 31, 2023 | 92.80% |
November 30, 2023 | 91.17% |
October 31, 2023 | 79.75% |
September 30, 2023 | 78.27% |
August 31, 2023 | 78.27% |
July 31, 2023 | 78.27% |
June 30, 2023 | 78.27% |
May 31, 2023 | 76.22% |
April 30, 2023 | 70.21% |
March 31, 2023 | 70.21% |
February 28, 2023 | 70.21% |
January 31, 2023 | 70.21% |
December 31, 2022 | 70.21% |
November 30, 2022 | 70.21% |
October 31, 2022 | 70.21% |
September 30, 2022 | 68.50% |
August 31, 2022 | 65.82% |
July 31, 2022 | 65.82% |
June 30, 2022 | 65.82% |
May 31, 2022 | 65.82% |
April 30, 2022 | 65.82% |
Date | Value |
---|---|
March 31, 2022 | 65.82% |
February 28, 2022 | 65.82% |
January 31, 2022 | 65.82% |
December 31, 2021 | 65.82% |
November 30, 2021 | 65.82% |
October 31, 2021 | 65.82% |
September 30, 2021 | 65.82% |
August 31, 2021 | 65.82% |
July 31, 2021 | 65.82% |
June 30, 2021 | 65.82% |
May 31, 2021 | 65.82% |
April 30, 2021 | 65.82% |
March 31, 2021 | 65.82% |
February 28, 2021 | 65.82% |
January 31, 2021 | 66.19% |
December 31, 2020 | 66.19% |
November 30, 2020 | 66.19% |
October 31, 2020 | 66.19% |
September 30, 2020 | 66.19% |
August 31, 2020 | 66.19% |
July 31, 2020 | 66.19% |
June 30, 2020 | 66.19% |
May 31, 2020 | 66.19% |
April 30, 2020 | 66.19% |
March 31, 2020 | 66.19% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
65.82%
Minimum
Feb 2021
93.70%
Maximum
Apr 2024
70.46%
Average
66.19%
Median
May 2019
Max Drawdown (5Y) Benchmarks
Soligenix Inc | 99.24% |
Marinus Pharmaceuticals Inc | 94.98% |
Inspire Medical Systems Inc | 61.59% |
NovaBay Pharmaceuticals Inc | 99.91% |
Palatin Technologies Inc | 96.46% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -46.88 |
Beta (5Y) | 0.4578 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 50.43% |
Historical Sharpe Ratio (5Y) | -0.8284 |
Historical Sortino (5Y) | -1.142 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 27.34% |